Furthermore, we suggested that Tob interacts with RIPK1 and NEMO and becomes integrated into the TNFR complex I. These molecular mechanisms could be connected to the enhanced NF-κB activation in breast cancer in the absence of Tob. The gene discussed is TOB1; the disease is breast carcinoma.